CellSource Co

CellSource Co Profit per Employee

The Profit per Employee of CellSource Co (4880.T) as of Nov 19, 2026 is 97,788.99 JPY. In the previous year, Profit per Employee was 2.18 M JPY — a change of -95.52% (lower).

Profit per Employee

97,788.99JPY

YoY

-95.52%

Last updated:

Profit per Employee of CellSource Co is 2025 97,788.99 JPY. Profit per Employee of CellSource Co was 2024 2.18 M JPY. It decreases by -95.52% lower compared to the previous year.

The CellSource Co Profit per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Profit per Employee
Date
Profit per Employee
Jan 1, 2018
1.77 M JPY
Jan 1, 2019
1.83 M JPY
Jan 1, 2020
2.51 M JPY
Jan 1, 2021
5.98 M JPY
Jan 1, 2022
9.34 M JPY
Jan 1, 2023
8.47 M JPY
Jan 1, 2024
2.18 M JPY
Jan 1, 2025
97,788.99 JPY
The CellSource Co Profit per Employee history
YEARProfit per EmployeeYoY
97,788.99JPY-95.52%
2.18 MJPY-74.22%
8.47 MJPY-9.30%
9.34 MJPY+56.26%
5.98 MJPY+137.66%
2.51 MJPY+37.31%
1.83 MJPY+3.21%
1.77 MJPY+73.61%
1.02 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CellSource Co Stock analysis

What does CellSource Co do? CellSource Co., Ltd. generates revenue through its Regenerative Medicine Related business segment, which provides contracted services for processing tissues and cells from fat and blood to medical institutions, along with support services for regenerative medicine laws and regulations related to safety assurance. The company also sells medical equipment within this segment. The Consumer business segment focuses on selling cosmetics and facial products directly to general consumers. Both segments operate under the company's brand without additional brand names mentioned in the description. The Regenerative Medicine Related business segment targets medical institutions and regulatory compliance support for regenerative medicine safety, while the Consumer business segment serves general consumers seeking cosmetics and facial care products. The company's products include processed tissue and cell services, regulatory support, medical equipment, and consumer skincare items, all sold under the CellSource brand. CellSource Co., Ltd. employs 109 full-time employees to manage its two business segments, with the Regenerative Medicine Related segment handling medical services and equipment sales, and the Consumer segment focusing on direct-to-consumer product sales. The company's revenue streams are derived from these two distinct operational areas without any additional external partnerships or third-party brands. CellSource Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CellSource Co stock

Profit per Employee of CellSource Co is 97,788.99 JPY in 2025.

Profit per Employee of CellSource Co changed from 2.18 M JPY to 97,788.99 JPY, representing a -95.52% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Profit per Employee CellSource Co since 2006 – with annual values, charts, and detailed analysis.

Profit per employee measures how much net income each employee generates on average. It is a key indicator of workforce efficiency.

Profit per Employee's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Profit per Employee's CellSource Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — CellSource Co

All Key Metrics — CellSource Co